PAX8 rs1191685: Genetic Influences on Sleep Duration
The single nucleotide polymorphism rs1191685 is an intergenic DNA variant located upstream of the PAX8 gene on chromosome 2. Large genome-wide association studies have identified this region as significantly associated with normal variations in nightly sleep duration. While carriers of the effect allele tend to report slightly longer sleep times on average, the overall evidence strength for direct clinical utility remains limited.
What each genotype means
Typical baseline sleep duration
You carry two copies of the common C allele for this PAX8-region variant. Large genome-wide association studies show this genotype is not linked to extended sleep duration, representing the standard genetic baseline for nightly sleep time in population studies. Because individual sleep duration is shaped by hundreds of genetic loci alongside lifestyle and environmental factors, this single variant accounts for only a minor fraction of overall sleep variation.
Carried by approximately 50% to 55% of individuals in European populations, and more common in many non-European ancestries.
Slightly increased sleep duration
You carry one copy of the T allele associated with subtle increases in sleep duration in European ancestry cohorts. Research indicates that each copy of this PAX8-linked allele corresponds to a modest statistical increase of roughly a few minutes of self-reported nightly sleep. This trait association does not diagnose a sleep disorder or guarantee longer sleep, as sleep patterns depend heavily on circadian rhythm genetics, overall health, and daily habits.
Carried by roughly 35% to 40% of people of European ancestry, with lower prevalence observed in East Asian and African ancestries.
Modestly increased sleep duration
You carry two copies of the T allele linked upstream of the PAX8 gene to longer habitual sleep duration. In European meta-analyses, individuals with this genotype average several minutes more sleep per night compared to non-carriers, although evidence remains limited in non-European ancestries. While statistically associated with longer sleep tendencies, this genotype has an incremental effect and does not replace the broad influence of environmental factors and overall sleep hygiene.
Carried by roughly 6% to 8% of individuals of European ancestry; it is substantially rarer in East Asian and African populations.
What Is rs1191685 and Where Is It Located?
The genetic variant rs1191685 represents a single nucleotide polymorphism (SNP) positioned on the forward strand of human chromosome 2 at a locus designated 2q14.1. Rather than falling inside a protein-coding sequence, rs1191685 sits within a non-coding intergenic region upstream of the PAX8 gene. In the human genome, variations at this site typically involve a single base substitution, most commonly an exchange between cytosine (C) and thymine (T) alleles. Because it resides outside the coding exons of nearby genes, rs1191685 does not directly alter an amino acid sequence in a protein. Instead, variants in this chromosomal block are believed to act as regulatory markers or to exist in linkage disequilibrium with other nearby genetic changes that influence regulatory elements, such as enhancers or transcription factor binding sites. In population genetics research, such as meta-analyses conducted by the CHARGE Consortium and the UK Biobank, rs1191685 is frequently cataloged as a tag variant for this genomic region.
Biological Role of the PAX8 Gene
The paired box gene 8 (PAX8) encodes a transcription factor containing a conserved paired box domain. In human physiology, PAX8 serves as a pivotal regulator of embryonic tissue organogenesis, specifically directing the proper formation of the thyroid gland, kidneys, and parts of the urogenital tract. Within adult tissues, PAX8 is indispensable for normal thyroid function, orchestrating the expression of essential thyroid-specific genes such as thyroglobulin and thyroid peroxidase. Although PAX8 is not classified as a core component of the cellular circadian transcription-translation feedback loop—such as CLOCK, BMAL1, or PER2—its profound role in thyroid biology provides a biological link to sleep. Thyroid hormone regulation strongly affects systemic metabolism, core body temperature, resting metabolic rate, and central nervous system alertness. Severe thyroid imbalances, such as untreated hypothyroidism, frequently result in lethargy, hypersomnolence, and disrupted sleep architectures, suggesting that subtle regulatory differences near PAX8 might influence broader sleep phenotypes.
What the Research Associates With rs1191685
Research into rs1191685 and related SNPs in the 2q14.1 region primarily stems from large-scale genome-wide association studies (GWAS) investigating self-reported and actigraphy-measured habitual sleep duration. Large meta-analyses including tens of thousands of participants from the CHARGE Consortium and UK Biobank identified statistically significant associations between variants in the PAX8 upstream region and usual sleep length. However, while statistical significance was high across multi-cohort samples, the absolute physiological effect size is modest: each copy of the associated allele corresponds to an estimated difference of only a few minutes of sleep per night (roughly 2 to 4 minutes per allele). The clinical evidence strength for this variant is currently categorized as limited because sleep duration is an intensely polygenic trait influenced by hundreds of distinct genomic loci interacting with environment, lifestyle, and psychosocial stress. Consequently, rs1191685 serves as a statistical association in population studies rather than a deterministic cause of sleep behavior.
Ancestry and Population Frequencies
The distribution of alleles at rs1191685 displays notable variation across global populations. In individuals of European continental ancestry, where the vast majority of sleep GWAS discovery cohorts have been concentrated, the minor allele frequency (MAF) is approximately 0.26. In other ancestral backgrounds, including African, Asian, and Admixed American groups cataloged in reference databases like dbSNP and gnomAD, allele frequencies can vary noticeably. While replication efforts in multi-ethnic cohorts, such as African-American samples, have observed concordant directional effects for the 2q14.1 PAX8 locus, overall research into non-European populations remains far less exhaustive. Because the frequency of the tagging allele and the surrounding linkage disequilibrium patterns can diverge among populations, researchers caution that effect sizes observed in European meta-analyses may not translate identically to individuals of diverse ancestral lineages.
Practical Implications: What This Means for You
Discovering your rs1191685 genotype provides interesting insight into how common genetic variation contributes to complex traits, but it cannot diagnose a sleep disorder or dictate your personal bedtime routine. A genetic marker with an effect size of a few minutes cannot overcome substantial lifestyle factors, such as caffeine intake, shift work, screen exposure before sleep, or chronic stress. A carrier of alleles associated with slightly shorter or longer habitual sleep is not inherently protected against insomnia, obstructive sleep apnea, or daytime fatigue. Similarly, because this variant is cataloged solely as a trait association rather than a clinical pharmacogenomic marker, it carries no recommendations for medication selection or dosing. Anyone experiencing chronic insomnia, non-restorative sleep, excessive daytime sleepiness, or potential symptoms of thyroid dysfunction should consult a qualified healthcare provider for clinical evaluation rather than relying on direct-to-consumer genetic data.
How common is this variant?
The minor allele frequency for rs1191685 is approximately 0.26 in populations of European ancestry. Frequencies vary in other ancestral populations according to global reference databases such as dbSNP and gnomAD.
Frequently asked questions
Can rs1191685 predict if I have a sleep disorder like insomnia or sleep apnea?
No. The rs1191685 variant is associated with very small, normal statistical differences in habitual sleep duration across populations, not pathological sleep disorders. Conditions like insomnia and obstructive sleep apnea require clinical diagnostic evaluations by healthcare professionals.
How much does my rs1191685 genotype actually change my sleep duration?
The effect is very subtle. In published genome-wide association studies, each copy of the associated allele accounts for only about 2 to 4 minutes of difference in total sleep per night, which is easily overshadowed by daily lifestyle habits, environment, and age.
Does this genetic variant mean I have a thyroid condition?
No. While the nearby PAX8 gene plays an important role in thyroid gland development and function, rs1191685 is merely a non-coding variant linked to sleep traits in population studies. It is not a clinical test for hypothyroidism or hyperthyroidism, which are diagnosed through standard blood panels.
Should I change my sleep schedule or medications based on this variant?
You should not alter your sleep schedule, sleep medications, or thyroid medications based on your rs1191685 genotype. This variant carries no clinical or pharmacogenomic dosing recommendations, and any treatment decisions should always be directed by a clinician.
Sources & further reading
Educational information only, last refreshed 9/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1191685?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29